Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice
Geng‐Ruei Chang, Weili Lin, Tzu-Chun Lin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11383-11383
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
Tingting Zhou, Ligang Cao, Yimei Du, et al.
PeerJ (2023) Vol. 11, pp. e15225-e15225
Open Access | Times Cited: 21
The therapeutic effects of saikosaponins on depression through the modulation of neuroplasticity: From molecular mechanisms to potential clinical applications
Chen Shen, Ke Wang, Hongzhan Wang, et al.
Pharmacological Research (2024) Vol. 201, pp. 107090-107090
Open Access | Times Cited: 11
Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review
Yuhan Ma, Yongxia Zhao, Mingxia Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
Pengyu Yao, Yajuan Liu
Molecules (2022) Vol. 28, Iss. 1, pp. 272-272
Open Access | Times Cited: 30
Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity
Hao Wu, Tianyu Lou, Mingxia Pan, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117841-117841
Closed Access | Times Cited: 5
Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
Juan Moreno‐Vedia, Josefa Girona, Daiana Ibarretxe, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 197-197
Open Access | Times Cited: 25
Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway
Yiqing Gu, Shuni Duan, Mingning Ding, et al.
Phytomedicine (2022) Vol. 103, pp. 154219-154219
Closed Access | Times Cited: 24
Hepatoprotective effects of propolis ethanol extract on D-galactose-induced aging mice: A metabolomics and transcriptomics analysis focusing on insulin resistance pathways
Jinjia Liu, Songhao Tian, Jixiang Wang, et al.
Journal of Functional Foods (2025) Vol. 125, pp. 106668-106668
Closed Access
The anti-inflammatory effects of saponins from natural herbs
Qi‐Tai Zheng, Tian Wang, Sensen Wang, et al.
Pharmacology & Therapeutics (2025), pp. 108827-108827
Closed Access
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Mohannad Mohammad S. Alamri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1080-1080
Open Access | Times Cited: 12
Saikosaponin b2 inhibits tumor angiogenesis in liver cancer via down‑regulation of VEGF/ERK/HIF‑1α signaling
Man You, Junmin Fu, Xingzhi Lv, et al.
Oncology Reports (2023) Vol. 50, Iss. 1
Open Access | Times Cited: 11
Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway
Nidhi Sharma, Taslim B. Shaikh, Abhisheik Chowdary Eedara, et al.
European Journal of Pharmacology (2022) Vol. 937, pp. 175366-175366
Closed Access | Times Cited: 18
Saponins and their derivatives: Potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance
Peirong Qu, Zhilin Jiang, Pingping Song, et al.
Pharmacological Research (2022) Vol. 182, pp. 106352-106352
Closed Access | Times Cited: 17
Novel insights into metabolic‐associated steatotic liver disease preclinical models
Rocío Montero‐Vallejo, Douglas Maya‐Miles, Javier Ampuero, et al.
Liver International (2024) Vol. 44, Iss. 3, pp. 644-662
Open Access | Times Cited: 3
Hepatic-Modulatory Effects of Chicken Liver Hydrolysate-Based Supplement on Autophagy Regulation against Liver Fibrogenesis
Yi‐Ling Lin, Chih‐Ying Chen, Deng-Jye Yang, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 493-493
Open Access | Times Cited: 7
Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling
Hui He, Jiaqi Guo, Yunxiang Hu, et al.
Acta Biochimica et Biophysica Sinica (2023)
Open Access | Times Cited: 7
Development of a functional cake with probiotics and micro-encapsulated essential oils: Evaluation of nutritional properties, liver protection, and immune boosting
Manal M. Ramadan, Eman F. El Haggar, Rasha S. Mohamed, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e22918-e22918
Open Access | Times Cited: 7
Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
Feng Zhang, Jiaming Ju, Hongtao Diao, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 2
Integrated 16S rRNA sequencing and nontargeted metabolomics analysis to reveal the mechanisms of Yu-Ye Tang on type 2 diabetes mellitus rats
Ziang Ma, Wenjuan Sun, Lixin Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5
Pharmacological properties and derivatives of saikosaponins—a review of recent studies
Yingchao Zhu, Yu Lai
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 7, pp. 898-909
Closed Access | Times Cited: 5
HDAC1 overexpression promoted by METTL3-IGF2BP2 inhibits FGF21 expression in metabolic syndrome-related liver injury
Yunjiang Chen, Kaiyu Cai, Yueling Du, et al.
Biochemistry and Cell Biology (2022) Vol. 101, Iss. 1, pp. 52-63
Closed Access | Times Cited: 8
MicroRNA-29a-3p Prevents Drug-Induced Acute Liver Failure through Inflammation-Related Pyroptosis Inhibition
Dan-dan Xiang, Jingtao Liu, Zibiao Zhong, et al.
Current Medical Science (2023) Vol. 43, Iss. 3, pp. 456-468
Closed Access | Times Cited: 4
Probing Liver Injuries Induced by Thioacetamide in Human In Vitro Pooled Hepatocyte Experiments
Himanshu Goel, Richard L. Printz, Venkat R. Pannala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3265-3265
Open Access | Times Cited: 1
A comprehensive review of bupleuri radix and its bioactive components： with a major focus on treating chronic liver diseases
Ying Zhong, Jianchao Li, Xiaomin Zhu, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118244-118244
Closed Access | Times Cited: 1
Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease
Yuqiao Liu, Yue Fan, Ji‐Bin Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top